Embecta

EMBC - EmbectaDividends

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding DateValue (U$)Frequency
8/27/2026
0,01
Quarterly
5/28/2026
0,01
Quarterly
2/27/2026
0,15
Quarterly
12/5/2025
0,15
Quarterly
8/29/2025
0,15
Quarterly
5/28/2025
0,15
Quarterly
2/28/2025
0,15
Quarterly
12/6/2024
0,15
Quarterly
8/27/2024
0,15
Quarterly
5/24/2024
0,15
Quarterly
2/27/2024
0,15
Quarterly
12/1/2023
0,15
Quarterly
8/24/2023
0,15
Quarterly
5/25/2023
0,15
Quarterly
2/24/2023
0,15
Quarterly
12/29/2022
0,15
Quarterly
1/2

The latest dividend from EMBC was $0.01 per share (ex-dividend 8/27/2026). The dividend yield over the last 12 months is 9,3%. Over the last 12 months there were 4 distributions, totalling $0.32 per share.